- Home
- FENC vs UHG Comparison
FENC vs UHG Comparison
Compare FENC & UHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- UHG
- Stock Information
- Founded
- FENC 1996
- UHG 2004
- Country
- FENC United States
- UHG United States
- Employees
- FENC N/A
- UHG N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- UHG Homebuilding
- Sector
- FENC Health Care
- UHG Consumer Discretionary
- Exchange
- FENC Nasdaq
- UHG Nasdaq
- Market Cap
- FENC 225.4M
- UHG 248.7M
- IPO Year
- FENC 2001
- UHG N/A
- Fundamental
- Price
- FENC $9.70
- UHG $4.04
- Analyst Decision
- FENC Strong Buy
- UHG
- Analyst Count
- FENC 2
- UHG 0
- Target Price
- FENC $13.50
- UHG N/A
- AVG Volume (30 Days)
- FENC 88.7K
- UHG 74.7K
- Earning Date
- FENC 11-06-2025
- UHG 11-07-2025
- Dividend Yield
- FENC N/A
- UHG N/A
- EPS Growth
- FENC N/A
- UHG N/A
- EPS
- FENC N/A
- UHG 0.10
- Revenue
- FENC $33,302,000.00
- UHG $445,963,017.00
- Revenue This Year
- FENC $0.18
- UHG N/A
- Revenue Next Year
- FENC $52.59
- UHG N/A
- P/E Ratio
- FENC N/A
- UHG $43.23
- Revenue Growth
- FENC N/A
- UHG 7.51
- 52 Week Low
- FENC $3.96
- UHG $1.60
- 52 Week High
- FENC $9.92
- UHG $6.93
- Technical
- Relative Strength Index (RSI)
- FENC 65.13
- UHG 51.71
- Support Level
- FENC $8.26
- UHG $3.82
- Resistance Level
- FENC $9.70
- UHG $4.47
- Average True Range (ATR)
- FENC 0.40
- UHG 0.26
- MACD
- FENC 0.11
- UHG -0.01
- Stochastic Oscillator
- FENC 90.58
- UHG 52.78
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About UHG United Homes Group Inc
United Homes Group Inc operates as a homebuilder which operates with a land-light idea in the Southeast. The company currently has a presence in South Carolina, North Carolina, and Georgia and focuses on providing high-quality, affordable homes for the entry-level and first-move-up segments. The company has three reportable segments: GSH South Carolina, Rosewood, and Other.